Synaptive Medical Received Investment from General Atlantic

synaptive_medicalSynaptive Medical, a Toronto, Canada-based medical device and technology company, received an investment from global growth equity firm General Atlantic.

The amount of the deal was not disclosed. In conjunction with the investment, David Caluori, Principal at General Atlantic, will join Synaptive’s board of directors, along with Alex Crisses, Managing Director at General Atlantic, who will join as an observer.

The company intends to use the funds to accelerate the commercialization of its existing solutions across worldwide markets and invest in new research and product development.

Founded in 2012 and led by Cameron Piron, President, Synaptive has developed BrightMatter™, a suite of products that provides visual and information tools allowing surgeons to focus on patient outcomes within a global healthcare industry. The company’s surgical technology, which combines informatics, imaging, surgical planning, navigation and advanced optics, has been installed at healthcare facilities across the United States, including recent installations at Emory University Hospital, the Gates Vascular Institute, Grady Health, Indiana University Health Methodist Hospital and Mount Sinai.



Join the discussion